Business Context and Reporting Period
This Form 8-K reports on the results of the 2017 Annual Meeting of Stockholders for Assembly Biosciences, Inc., held on June 1, 2017. The filing details the voting outcomes for director elections, executive compensation, and the ratification of the independent auditor.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Revenue, profit, cash flow, margins, debt, and liquidity metrics are not provided in this document.
Material Changes
No material financial changes are reported in this filing. The document focuses solely on the successful approval of shareholder proposals at the Annual Meeting.
Guidance, Outlook, and Voting Results
All three matters submitted to stockholders were approved. The total number of shares entitled to vote was 17,305,044, with 13,985,926 shares present or represented by proxy.
- Election of Directors: All seven nominees were elected. William R. Ringo, Jr. received the highest number of votes withheld (268,647) compared to other nominees, who received between 3,083 and 4,388 votes withheld. There were 1,410,744 broker non-votes.
- Executive Compensation: The non-binding advisory resolution was approved with 12,548,520 votes for, 13,935 against, and 12,727 abstentions. There were 1,410,744 broker non-votes.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2017. The vote was 13,974,440 for, 1,628 against, and 9,858 abstained. There were no broker non-votes.
Investor Verification Checklist
- Verify the specific reasons for the significantly higher number of votes withheld for director nominee William R. Ringo, Jr. compared to other nominees.
- Review the Proxy Statement filed on April 21, 2017, for detailed descriptions of the proposals and director biographies.
- Confirm the company's financial status and cash runway by reviewing the most recent 10-K or 10-Q filings, as this 8-K contains no financial data.